Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemia.
Jetani H, Navarro-Bailón A, Maucher M, Frenz S, Verbruggen C, Yeguas A, Vidriales MB, González M, Rial Saborido J, Kraus S, Mestermann K, Thomas S, Bonig H, Luu M, Monjezi R, Mougiakakos D, Sauer M, Einsele H, Hudecek M.
Jetani H, et al. Among authors: maucher m.
Blood. 2021 Nov 11;138(19):1830-1842. doi: 10.1182/blood.2020009192.
Blood. 2021.
PMID: 34289026
Free PMC article.